Scientists work toward a vaccine for filoviruses, Ebola’s deadly kin

Vaccination and sampling schedule for RV456/EBL2003 Phase 2 Ad26/MVA Ebola vaccine trial. Credit: Science Translational Medicine (2025). DOI: 10.1126/scitranslmed.adq2496

Continue Reading